Dainippon Pursues Organ Generation In New Alliance With Japan Partners

Sumitomo Dainippon Pharma has entered into a new alliance with a group of academic and venture partners in Japan to conduct basic research into regenerative medicine, that will focus on building expertise in organ regeneration for renal disorders.

Stem cells on colorful background, 3D illustration
SDP Pursues Regenerative Medicine Initiative • Source: Shutterstock

More from Cell Therapies

More from Advanced Therapies